Welcome to our dedicated page for CONCENTRA GROUP HOLDINGS PAREN news (Ticker: CON), a resource for investors and traders seeking the latest updates and insights on CONCENTRA GROUP HOLDINGS PAREN stock.
Concentra Group Holdings Parent, Inc. (NYSE: CON) generates a steady flow of news as a major participant in U.S. occupational health and employer-focused medical services. Company announcements frequently highlight the expansion of its national network of occupational health centers and onsite health clinics, financial performance updates, and developments in governance and data strategy. For readers tracking CON news, these items provide insight into how the company is growing its footprint and managing its role as a large-scale provider of workplace health services.
News releases often cover the opening of new medical centers in markets such as Hialeah, Florida; Corona, California; and Union City, Georgia. These updates describe the services offered at new locations, including work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services, as well as telemedicine for minor work injuries through Concentra Telemed. Such stories illustrate how Concentra extends access to occupational health services for employers and employees in additional regions.
Investors and observers will also find regular coverage of Concentra’s quarterly financial results, including revenue trends, patient visit metrics, and the growth of its network of occupational health centers and onsite health clinics. Related announcements may include dividend declarations, share repurchase authorizations, and commentary from company leadership on strategy, acquisitions, and technology investments.
Additional news items focus on corporate actions such as the acquisition of Pivot Onsite Innovations, which expanded Concentra’s onsite health clinics business, and the appointment of new board members and a Chief Data, Analytics, and Artificial Intelligence Officer. Together, these updates provide a detailed view of how Concentra is evolving its operations, governance, and data capabilities within the occupational health sector. This news page brings these developments together in one place for those following CON.
Concentra (NYSE: CON) reported preliminary unaudited results for Q4 and FY2025 and provided full‑year 2026 guidance. Key 2025 metrics: FY revenue $2,163.4M (+13.9%), Adjusted EBITDA $431.9M (+14.6%), free cash flow $197.8M, capital expenditures $82.3M (+28%), and net leverage ~3.4x. Q4 revenue was $539.1M and Adj EBITDA $95.3M. For 2026 the company expects revenue $2.25–2.35B, Adjusted EBITDA $450–470M, free cash flow $200–225M, and target net leverage ≤3.0x. Full results will be released Feb 26, 2026 with a conference call Feb 27, 2026.
Concentra (NYSE: CON) announced the opening of a new medical center in Tucker, Georgia, located at 4434 Hugh Howell Road, Tucker, GA 30084 on January 26, 2026. The center will provide work injury care, physical therapy, drug testing, DOT and pre-placement exams, employer-related services, and telemedicine via Concentra Telemed. Concentra operates an extensive network—628 occupational health centers and 409 onsite clinics serving more than 50,000 patients daily as of September 30, 2025.
Concentra (NYSE: CON) announced the opening of a new medical center in Hialeah, Florida on December 15, 2025. The new Concentra Hialeah is located at 855 East 8th Avenue, Hialeah, FL 33010 and will offer work injury care, physical therapy, drug testing, DOT physicals, pre-placement exams and other employer-related health services.
The center will also provide telemedicine for minor work injuries via Concentra Telemed. The expansion adds to Concentra’s national footprint of 628 occupational health centers and 409 onsite clinics, serving more than 50,000 patients daily with approximately 13,000 colleagues as of September 30, 2025.
Concentra (NYSE: CON) opened a new occupational health center in Corona, California on December 8, 2025 at 629 North Main Street, Unit C-3, Corona, CA 92878.
The center will offer work injury care, physical therapy, drug testing, DOT and pre-placement exams, employer-related health services, and telemedicine via Concentra Telemed. Concentra operates an extensive network of occupational health sites, reporting 628 centers, 409 onsite clinics, and about 13,000 colleagues supporting >50,000 patient visits daily as of September 30, 2025.
Concentra (NYSE: CON) appointed Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer on November 10, 2025. Cooper will lead data strategy, governance, technology enablement, and insight generation to align analytics and AI with enterprise growth priorities.
Cooper brings over 25 years of experience across private, for-profit, and nonprofit sectors, with prior roles at L3-Communications, MATRIC, CVS Caremark, Cigna, Blue Cross Blue Shield plans, HMS, and Paradigm Corp. He holds memberships with the Society for Information Management and is a Fellow of the American College of Health Data Management.
Concentra operates 628 occupational health centers and 413 onsite clinics, serving more than 50,000 patients daily as of September 30, 2025.
Concentra (NYSE: CON) reported strong third quarter 2025 results, announcing a cash dividend and a $100 million share repurchase authorization while raising full‑year 2025 guidance.
Key Q3 metrics: Revenue $572.8M (+17.0% YoY), Adjusted EBITDA $118.9M (+17.1% YoY), net income $49.8M, and 3,557,697 patient visits. Cash was $49.9M and net leverage improved to 3.6x at 9/30/2025. Board declared a $0.0625 per share dividend payable ~Dec 9, 2025, and authorized up to $100M repurchases through 12/31/2027.
Raised 2025 outlook: Revenue $2.145B–$2.160B, Adjusted EBITDA $425M–$430M, CapEx $80M–$90M, and target net leverage ≤3.5x by year-end 2025.
Concentra (NYSE: CON) will release third quarter 2025 financial results for the period ended September 30, 2025 on Thursday, November 6, 2025 after market close.
The company will host a conference call and live webcast to discuss results on Friday, November 7, 2025 at 9:00 a.m. ET. Investors can join via the live webcast on Concentra's investor relations site or use the audio-only dial-in: Toll Free 888-506-0062, International 973-528-0011, Participant Access Code 313858. A replay of the webcast will be available shortly after the call at the same locations.
Concentra (NYSE: CON), the leading occupational medicine provider in the United States, has announced the opening of a new medical center in Union City, Georgia. Located at 6851 Shannon Parkway, the facility expands Concentra's presence in the Atlanta area.
The new center will offer comprehensive occupational health services including work injury care, physical therapy, drug testing, DOT physical exams, and pre-placement exams. Additionally, the facility will provide telemedicine services through Concentra Telemed® for minor work injuries. This expansion adds to Concentra's extensive network of over 620 locations nationwide.
Concentra (NYSE:CON), the largest U.S. occupational health services provider, reported strong Q2 2025 results with revenue of $550.8M, up 15.2% year-over-year. The company achieved net income of $46.2M and Adjusted EBITDA of $115.0M, a 13.2% increase from Q2 2024.
Key operational metrics showed substantial growth, with patient visits increasing 9.5% to 55,005 per day and revenue per visit rising 4.4% to $145.92. The company completed the acquisition of Pivot Onsite Innovations, expanding its network to over 1,000 combined locations, including 628 occupational health centers and 406 onsite clinics.
Concentra raised its FY 2025 guidance, now expecting revenue of $2.13-2.16B and Adjusted EBITDA of $420-430M. The company also declared a cash dividend of $0.0625 per share, payable August 28, 2025.
Concentra (NYSE:CON) has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close. The company will host a conference call to discuss the results on Friday, August 8, 2025, at 9:00 a.m. Eastern Time.
Investors can access the live webcast through the provided Earnings Call Webcast Link or via Concentra's investor relations website. An audio-only option and Q&A session will be available via toll-free (888-506-0062) and international (973-528-0011) dial-in numbers.